| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |